Genetic testing and management of prostate cancer patients with pathogenic germline variants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Genetic testing and management of prostate cancer patients with pathogenic germline variants ; day:3 ; month:11 ; year:2023 ; pages:1-6
Magazine of European Medical Oncology ; (3.11.2023), 1-6
- Urheber
-
Reiter, Katharina
Hassler, Melanie R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-023-00921-1
- URN
-
urn:nbn:de:101:1-2024012212170917140369
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Reiter, Katharina
- Hassler, Melanie R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with osteosarcoma and ependymoma
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with osteosarcoma and ependymoma
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with osteosarcoma and ependymoma
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer